The present invention is concerned with novel sulfonamides of formula ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3 and n are as described in the description and claims. The compounds are orexin receptor antagonists, useful in the treatment of disorders, in which orexin pathways are involved.

 
Web www.patentalert.com

< COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V LEIDEN MUTANT GENE

> Self-Emulsifying Formulations of CETP Inhibitors

> Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1

~ 00533